Coya Therapeutics (COYA) Payables (2021 - 2026)

Coya Therapeutics has disclosed Payables across 6 years of filings, most recently posting $1.1 million for Q2 2026.

• In Q2 2026, Payables rose 16.55% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $1.1 million (up 16.55% YoY), while the FY2025 annual figure was $1.1 million, down 33.18% from the prior year.
• Payables came in at $1.1 million for Q2 2026 at Coya Therapeutics, up from $948192.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $1.9 million in Q2 2024 to a low of $237579.0 in Q2 2023.
• Average Payables over 5 years is $1.1 million, with a median of $1.1 million recorded in 2026.
• Year-over-year, Payables soared 692.61% in 2024 and sank 50.54% in 2025.
• Over 5 years, Payables stood at $1.8 million in 2022, then sank by 36.34% to $1.2 million in 2023, then soared by 37.42% to $1.6 million in 2024, then tumbled by 33.18% to $1.1 million in 2025, then advanced by 2.3% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.1 million in Q2 2026, $948192.0 in Q1 2026, and $1.1 million in Q4 2025.